Newsroom ARCHIVE
Welcome to the newsroom archive
of AOP Health
Please find below archived press releases
Press Releases
Explore the archived press releases about AOP Health, its products, studies and cooperations. We will be happy to answer any questions or comments you may have via aop-health@aoporphan.com
AOP Orphan Pharmaceuticals präsentiert neueste Analysen zu BESREMi® (Ropeginterferon alfa-2b) bei Polycythaemia vera beim renommierten Jahreskongress der American Society of Hematology (ASH) 2021
14. 12. 2021
November ist PH Awareness Monat
15. 11. 2021
BESREMi® (Ropeginterferon alfa-2b) approved by the US FDA
15. 11. 2021
Arzneimittelforschung für seltene Erkrankungen: Welche Rahmenbedingungen sind notwendig?
18. 10. 2021
Can European Solutions Allow Equal Access to Rare Disease Drugs in All European Countries?
6. 10. 2021
Austrian AOP Orphan to Tap into U.S. Market with Partner Eagle Pharmaceuticals
28. 9. 2021